VC / CVC
2022
$107 M
Berlin, Germany
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
naturalX Health Ventures is a venture capital firm based in Berlin, Germany, founded in 2022. The firm is backed by Schwabe Group, a global leader in plant-based pharmaceuticals, and aims to be the go-to investor in Consumer Health across Europe. The team is led by Marvin Amberg, Managing Director, and includes professionals like Clementine Provost and Yang Chen, PhD. naturalX Health Ventures distinguishes itself by focusing on the intersection of wellness and medicine, bridging traditional and digital health solutions.
The firm primarily invests in consumer health startups with scientifically-backed products and solutions. Their investment focus is on Series A and Series B stages, with flexibility to invest from seed to late stage. Typical investment sizes range from €3-5 million, with the ability to reserve up to €10 million per company. naturalX Health Ventures has a total AUM of €100 million and is actively investing across Europe, particularly in Switzerland.
Notable investments include Jutro Medical - a digital healthcare provider, Function Health - a consumer health platform for lab testing, Hilo - a wearable for blood pressure monitoring, Kyan Health - an AI-powered workplace wellbeing solution, and Flow Neuroscience - a brain stimulation headset for depression. These investments highlight the firm's commitment to proactive and mental health solutions.
Industry
Region of investment
naturalX Health Ventures Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
naturalX Ventures Fund I
|
Venture Capital (VC)
|
Consumer Products
Consumer Services (B2C)
Healthcare Services
HealthTech
|
Seed
Series A
Series B
|
Europe
|
$5-10 m
|
$107 M
|
February 2025
|